ProPred analysis and experimental evaluation of promiscuous T-cell epitopes of three major secreted antigens of Mycobacterium tuberculosis

被引:78
作者
Mustafa, AS [1 ]
Shaban, FA [1 ]
机构
[1] Kuwait Univ, Fac Med, Dept Microbiol, Safat 13110, Kuwait
关键词
M; tuberculosis; secreted antigens; ProPred; promiscuous epitopes;
D O I
10.1016/j.tube.2005.05.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In the search for safe vaccine candidates against tuberculosis (TB), subunit vaccines including peptide-based candidates deserve consideration. However, an important requirement for such vaccine candidates is their promiscuous presentation to Th1 cells mediating protective immunity against TB, i.e. Th1 cells secreting IFN-gamma. The aim of the present study was to identify promiscuous Th1 cell epitopes of three major secreted antigens of Mycobacterium tuberculosis, i.e. ESAT-6, CFP10 and MPT70 by using a virtual matrix-based prediction program (ProPred) for peptide binding to 51 HLA-DR alleles. The ProPred analysis of these proteins was performed using the server (http://www.imtech.res.in/raghava/propred/). The peptides predicted to bind >50% HLA-DR alleles included in the ProPred were considered promiscuous for binding predictions. Based on this criteria, one region in ESAT-6 (aa 69-77), two regions in CFP10 (aa 55-66 and aa 76-84) and four regions in MPT70 (aa 1-11, aa 81-95, aa 124-140 and aa 182-191) were considered promiscuous HLA-DR binders. The experimental evaluation of these regions, by using overlapping synthetic peptides for presentation to T-cells, confirmed the promiscuous nature of peptides covering the regions aa 69-77, aa 76-84 and aa 182-191 of ESAT-6, CFP10 and MPT70, respectively. These results demonstrate that the ProPred analysis can facilitate the selection of promiscuous peptides recognized by Th1 cells, and thus it can be useful in the identification of peptide-based vaccine candidates against TB. (C) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:115 / 124
页数:10
相关论文
共 38 条
[11]   From genome to vaccine: in silico predictions, ex vivo verification [J].
De Groot, AS ;
Bosma, A ;
Chinai, N ;
Frost, J ;
Jesdale, BM ;
Gonzalez, MA ;
Martin, W .
VACCINE, 2001, 19 (31) :4385-4395
[12]   An interactive web site providing major histocompatibility ligand predictions: Application to HIV research [J].
DeGroot, AS ;
Jesdale, BM ;
Szu, E ;
Schafer, JR ;
Chicz, RM ;
Deocampo, G .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1997, 13 (07) :529-531
[13]   Tuberculosis [J].
Frieden, TR ;
Sterling, TR ;
Munsiff, SS ;
Watt, CJ ;
Dye, C .
LANCET, 2003, 362 (9387) :887-899
[14]   Computers aid vaccine design [J].
Hagmann, M .
SCIENCE, 2000, 290 (5489) :80-82
[15]  
Hammer J, 1997, ADV IMMUNOL, V66, P67, DOI 10.1016/S0065-2776(08)60596-9
[16]   PRECISE PREDICTION OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II PEPTIDE INTERACTION BASED ON PEPTIDE SIDE-CHAIN SCANNING [J].
HAMMER, J ;
BONO, E ;
GALLAZZI, F ;
BELUNIS, C ;
NAGY, Z ;
SINIGAGLIA, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (06) :2353-2358
[17]   Melanoma cells present a MAGE-3 epitope to CD4+ cytotoxic T cells in association with histocompatibility leukocyte antigen DR11 [J].
Manici, S ;
Sturniolo, T ;
Imro, MA ;
Hammer, J ;
Sinigaglia, F ;
Noppen, C ;
Spagnoli, G ;
Mazzi, B ;
Bellone, M ;
Dellabona, P ;
Protti, MP .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (05) :871-876
[18]  
Mustafa A. S., 2001, Current Pharmaceutical Biotechnology, V2, P157, DOI 10.2174/1389201013378707
[19]   Identification of promiscuous epitopes from the mycobacterial 65-kilodalton heat shock protein recognized by human CD4+ T cells of the Mycobacterium leprae memory repertoire [J].
Mustafa, AS ;
Lundin, KEA ;
Meloen, RH ;
Shinnick, TM ;
Oftung, F .
INFECTION AND IMMUNITY, 1999, 67 (11) :5683-5689
[20]   Identification and HLA restriction of naturally derived Th1-cell epitopes from the secreted Mycobacterium tuberculosis antigen 85B recognized by antigen-specific human CD4+ T-cell lines [J].
Mustafa, AS ;
Shaban, FA ;
Abal, AT ;
Al-Attiyah, R ;
Wiker, HG ;
Lundin, KEA ;
Oftung, F ;
Huygen, K .
INFECTION AND IMMUNITY, 2000, 68 (07) :3933-3940